Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Notice of calling the annual general meeting of Hepsor AS
-
SHAREHOLDER DEADLINE: Zynex (ZYXI) Investors Are Reminded of Deadline in Securities Action
-
Vivendi: Significant Decrease in the Financial Net Debt in the First Quarter of 2025
-
ONWARD Medical Announces Release of 2024 Annual Report
-
Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business
-
Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business
-
Interoil's Annual Statement of Reserves 2024 released
-
Scania Performance Summary January-March 2025
-
NASDAQ: VTRS CLASS ACTION NOTICE: Berger Montague Encourages Viatris (VTRS) Investors to Inquire About a Securities Fraud Class Action
-
Dividend - Currency Election and Payment Currency Update
-
Global Tactical Metals Strengthens U.S. Defense Industry Ties Through NDIA Membership Amid Historic Defense Spending Surge
-
Ynvisible Announces Strategic Manufacturing and Commercial Partnership with CCL Design
-
Cornish Metals Corporate Update – Senior Management Appointments
-
Empire Metals Limited - Extensive High-Grade Titanium Zones Confirmed
-
Hemogenyx Pharmaceuticals PLC Announces Final Results
-
Orosur Mining Inc Announces Results for Third Quarter ended February 28th 2025
-
Fair Home: Valued Effort: Pairwork App Launches in the US to Quantify Housework
-
Cornish Metals Announces Management Change
-
Pulsar Helium Announces an Update for Well-Testing at the Topaz Helium Project in Minnesota
-
Lleida.net increased its sales by 16% in 2024 and recorded profits of €883,000, according to its audited data
-
NBPE Announces Audited 2024 Results and 31 March 2025 Est. NAV
-
LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland
-
Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation for PS-002 for the treatment of patients with primary IgA nephropathy (IgAN)
-
Mantra Softech extends licence for FPC iris technology to expand into new markets
-
NB Private Equity Partners Announces Transaction in Own Shares
-
FreeMove Alliance and du cooperate to better serve Multinationals in the United Arab Emirates
-
YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia
-
Sonata Software Secures a $73 Million AI-led Digital Modernization Deal with a Leading US TMT Company
-
Transaction in Own Shares
-
Exosens delivers strong revenue growth in Q1 2025 in a dynamic defense market environment; Fully on track to 2025 guidance
-
24/2025・Trifork Group: Weekly report on share buyback
-
Vallourec Awarded a Major Contract by Kuwait Oil Company
-
Publication annual report and convocation of the ordinary general meeting on May 28, 2025
-
Dr. Zahi Hawass, The World's Most Famous Archaeologist, Returns to North America With Groundbreaking Discoveries
-
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets
-
Colle AI Broadens Solana Support to Accelerate Scalable NFT Infrastructure Development
-
Atua AI Scales XRP Cryptocurrency Infrastructure to Enhance AI-Powered Financial Operations
-
Introducing Reversec: Shaping the future of offensive cybersecurity
-
Number of Shares and Voting Rights of Innate Pharma as of April 25, 2025
-
BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025
-
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine
-
Start of Day Message
-
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
-
Sigenergy Becomes Australia's Top Battery Brand by Market Share, SunWiz Reports
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Everus Construction Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ECG
-
100 Days Into New Administration, Survey Reveals Key Opportunities for Elected Officials to Restore Voter Confidence in the Economy
-
LvLogics Launches Innovative Bin Monitoring Solution for Feed Mills
-
Must-Read Book For All Christians Explores Conflict, Transformation, Spiritual Warfare and Becoming More Like Christ
-
The Unexpected Journey of an Angry Man and a Persistent Black Bear
-
Mad City Windows & Baths Expands to Scranton, PA with Full Suite of Home Remodeling Services

